JCR Pharmaceuticals Management
Management criteria checks 2/4
JCR Pharmaceuticals' CEO is Hiroyuki Sonoda, appointed in Jun 2018, has a tenure of 6.42 years. directly owns 0.056% of the company’s shares, worth $191.50K. The average tenure of the management team and the board of directors is 6.2 years and 5.7 years respectively.
Key information
Hiroyuki Sonoda
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 8yrs |
| CEO ownership | 0.06% |
| Management average tenure | 6.2yrs |
| Board average tenure | 5.7yrs |
Recent management updates
Recent updates
CEO
Hiroyuki Sonoda (48 yo)
Mr. Hiroyuki Sonoda, Ph D., serves as Representative Director & President since April 1, 2026 and is Chief Scientific Officer since 2026 and was Executive Director of Research Division and Director at JCR...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board | less than a year | no data | 0.30% $ 1.0m | |
| President | 8yrs | no data | 0.056% $ 191.5k | |
| Founder & Director | less than a year | no data | 0.20% $ 679.4k | |
| Director of Accounting Department & Corporate Strategy Department (Finance) | no data | no data | no data | |
| Senior Managing Executive Officer | 10yrs | no data | no data | |
| Exec Off | less than a year | no data | no data | |
| Director of Marketing Dept. & Sales Division | less than a year | no data | no data | |
| Director of Human Resources Department & Administration Division | no data | no data | no data | |
| Executive Vice President | 15.9yrs | no data | no data | |
| Senior Advisor | 15.1yrs | no data | no data | |
| Senior Executive Officer & Director of International Affairs | no data | no data | no data | |
| Senior Managing Executive Officer & Executive Director of Business Development Division | 2.4yrs | no data | no data |
Experienced Management: JCRR.F's management team is seasoned and experienced (6.2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman of the Board | less than a year | no data | 0.30% $ 1.0m | |
| President | 6.4yrs | no data | 0.056% $ 191.5k | |
| Founder & Director | 21yrs | no data | 0.20% $ 679.4k | |
| Director | 5yrs | no data | 0.035% $ 119.2k | |
| Senior Managing Executive Officer of Development Division & Director | 2yrs | no data | 0.025% $ 84.1k | |
| Independent Outside Director | 3yrs | no data | 0.0016% $ 5.6k | |
| Independent Outside Director | 4yrs | no data | 0.0016% $ 5.6k | |
| Independent Outside Director | 8yrs | no data | no data | |
| Outside Audit & Supervisory Board Member | 13yrs | no data | 0.010% $ 34.7k | |
| Independent Outside Director | 4yrs | no data | 0.0016% $ 5.6k | |
| Independent Outside Director | 9yrs | no data | 0.0016% $ 5.6k | |
| Independent Outside Director | 8yrs | no data | no data |
Experienced Board: JCRR.F's board of directors are considered experienced (5.7 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/13 07:28 |
| End of Day Share Price | 2026/06/01 00:00 |
| Earnings | 2026/03/31 |
| Annual Earnings | 2026/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
JCR Pharmaceuticals Co., Ltd. is covered by 15 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Tatsuyuki Arai | BofA Global Research |
| Hidemaru Yamaguchi | Citigroup Inc |
| Kazuaki Hashiguchi | Daiwa Securities Co. Ltd. |